Who Benefits Most From Adjuvant Interferon Treatment for Melanoma?
|
journal
|
January 2015 |
Which drug, and when, for patients with BRAF-mutant melanoma?
|
journal
|
February 2013 |
Prognostic Factors for Overall Survival After Radiosurgery for Brain Metastases From Melanoma
|
journal
|
January 2014 |
Treatment Algorithms in Stage IV Melanoma
|
journal
|
January 2015 |
Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy
|
journal
|
September 2015 |
Combination cancer immunotherapy and new immunomodulatory targets
|
journal
|
July 2015 |
S100 proteins in cancer
|
journal
|
January 2015 |
Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients
|
journal
|
March 2013 |
Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B protein: Plasmatic Proteasomes and Malignant Melanoma
|
journal
|
January 2013 |
18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma
|
journal
|
January 2013 |
Lack of Elevation of Serum S100B in Patients with Metastatic Melanoma as a Predictor of Outcome After Induction with an Autologous Vaccine of Proliferating Tumor Cells and Dendritic Cells
|
journal
|
April 2008 |
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
|
journal
|
April 2003 |
The Calcium-binding Protein S100B Down-regulates p53 and Apoptosis in Malignant Melanoma
|
journal
|
August 2010 |
Inhibiting S100B Restores p53 Levels in Primary Malignant Melanoma Cancer Cells
|
journal
|
August 2004 |
Identification and Characterization of Small Molecule Inhibitors of the Calcium-Dependent S100B−p53 Tumor Suppressor Interaction
|
journal
|
October 2004 |
The evolution of S100B inhibitors for the treatment of malignant melanoma
|
journal
|
January 2013 |
Inhibiting S100B in Malignant Melanoma
|
book
|
January 2013 |
RAGE overexpression confers a metastatic phenotype to the WM115 human primary melanoma cell line
|
journal
|
July 2014 |
Pentamidine-Associated Nephrotoxicity and Hyperkalemia in Patients with Aids
|
journal
|
November 1991 |
Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties
|
journal
|
August 1992 |
Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100B
|
journal
|
September 2012 |
Fragmenting the S100B-p53 Interaction: Combined Virtual/Biophysical Screening Approaches to Identify Ligands
|
journal
|
February 2010 |
Identification of small-molecule inhibitors of the human S100B–p53 interaction and evaluation of their activity in human melanoma cells
|
journal
|
March 2013 |
Anatomy of hot spots in protein interfaces
|
journal
|
July 1998 |
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
|
journal
|
April 2010 |
Divalent Metal Ion Complexes of S100B in the Absence and Presence of Pentamidine
|
journal
|
September 2008 |
Covalent Small Molecule Inhibitors of Ca 2+ -Bound S100B
|
journal
|
October 2014 |
4-(Cyclic Amidino)phenols - Preparation and Use In A Diamidine Synthesis
|
journal
|
March 2000 |
Synthesis and α-blocking activity of some analogues of idazoxan
|
journal
|
July 1987 |
In Vitro Structure−Activity Relationship and In Vivo Characterization of 1-(Aryl)-3-(4-(amino)benzyl)urea Transient Receptor Potential Vanilloid 1 Antagonists
|
journal
|
June 2007 |
Cyclodextrin Dimers as Receptor Molecules for Steroid Sensors
|
journal
|
November 2000 |
The Effects of CapZ Peptide (TRTK-12) Binding to S100B–Ca2+ as Examined by NMR and X-ray Crystallography
|
journal
|
March 2010 |
In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction
|
journal
|
July 2010 |
A novel mode of target recognition suggested by the 2.0 å structure of holo S100B from bovine brain
|
journal
|
February 1998 |
Small Molecules Bound to Unique Sites in the Target Protein Binding Cleft of Calcium-Bound S100B As Characterized by Nuclear Magnetic Resonance and X-ray Crystallography
|
journal
|
June 2009 |
Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B
|
journal
|
November 2006 |
Target Binding to S100B Reduces Dynamic Properties and Increases Ca2+-Binding Affinity for Wild Type and EF-Hand Mutant Proteins
|
journal
|
October 2012 |
Direct measurement of cell numbers in microtitre plate cultures using the fluorescent dye SYBR green I
|
journal
|
January 1998 |
Solution Structure of Rat Apo-S100B(ββ) As Determined by NMR Spectroscopy † , ‡
|
journal
|
January 1996 |
An automated system to mount cryo-cooled protein crystals on a synchrotron beamline, using compact sample cassettes and a small-scale robot
|
journal
|
November 2002 |
New paradigm for macromolecular crystallography experiments at SSRL: automated crystal screening and remote data collection
|
journal
|
November 2008 |
Blu-Ice and the Distributed Control System : software for data acquisition and instrument control at macromolecular crystallography beamlines
|
journal
|
November 2002 |
Solving structures of protein complexes by molecular replacement with Phaser
|
journal
|
December 2006 |
Phaser crystallographic software
|
journal
|
July 2007 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
Features and development of Coot
|
journal
|
March 2010 |
Computational Fragment-Based Binding Site Identification by Ligand Competitive Saturation
|
journal
|
July 2009 |
Reproducing Crystal Binding Modes of Ligand Functional Groups Using Site-Identification by Ligand Competitive Saturation (SILCS) Simulations
|
journal
|
March 2011 |
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
|
journal
|
January 2009 |
Inclusion of Multiple Fragment Types in the Site Identification by Ligand Competitive Saturation (SILCS) Approach
|
journal
|
November 2013 |
Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing
|
journal
|
November 2012 |
Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges
|
journal
|
November 2012 |
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields
|
journal
|
January 2009 |
Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf
|
journal
|
April 2015 |
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|
journal
|
June 2012 |
Complex Formation between S100B Protein and the p90 Ribosomal S6 Kinase (RSK) in Malignant Melanoma Is Calcium-dependent and Inhibits Extracellular Signal-regulated Kinase (ERK)-mediated Phosphorylation of RSK
|
journal
|
May 2014 |
Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine–resistant cancer cells
|
journal
|
June 2005 |
The Effects of CapZ Peptide (TRTK-12) Binding to S100B-Ca2+ as Examined by NMR and X-ray Crystallography
|
dataset
|
January 2010 |